Colistin resistance in carbapenem-resistant Klebsiella pneumoniae strains

Beena Hosdurg Bhaskar, Shalini Shenoy Mulki, Sangeeta Joshi, Ranjeeta Adhikari, Bhavana Malavalli Venkatesh

Research output: Contribution to journalArticle

Abstract

Objective: There is an increasing use of colistin consequent to increase in the infections caused by carbapenem-resistant Klebsiella pneumoniae. The present study was conducted to determine the minimum inhibitory concentration (MIC) of colistin and the resistance pattern of colistin in carbapenem-resistant K. pneumoniae (CRKP) strains in our intensive care unit (ICU). Methods: Antibiotic susceptibility testing for other antimicrobial agents was done by Kirby-Bauer disk diffusion method. MIC of colistin was determined by agar dilution method. The results of antibiotic susceptibility testing were interpreted as per Clinical Laboratory Standard Institute guidelines 2016 and MIC of colistin were interpreted as per European Committee on Antimicrobial susceptibility testing. The carbapenem resistance was phenotypically detected by modified hodge test and imipenem/imipenem ethylenediaminetetraacetic acid disk method. Results: Out of 518 K. pneumoniae, 329 were resistant to carbapenems, and 91 isolates showed resistance to colistin. The MIC of colistin ranged between 4 and >512 ug/ml and MIC90 was 16 ug/L and MIC50 was 4 ug/ml. A majority of the colistin-resistant isolates were found in multidisciplinary ICU (85/91). Conclusion: The emergence of colistin-resistant strains is a major problem due to limited treatment options for infections caused by CRKP carbapenemase producing K. pneumoniae. Colistin should not be used alone, combination therapy should be preferred.

Original languageEnglish
Pages (from-to)70-73
Number of pages4
JournalAsian Journal of Pharmaceutical and Clinical Research
Volume10
Issue number9
DOIs
Publication statusPublished - 01-01-2017
Externally publishedYes

Fingerprint

Colistin
Carbapenems
Klebsiella pneumoniae
Microbial Sensitivity Tests
Imipenem
Intensive Care Units
Disk Diffusion Antimicrobial Tests
Anti-Bacterial Agents
Anti-Infective Agents
Infection
Edetic Acid
Agar
Guidelines

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science
  • Pharmacology (medical)

Cite this

Bhaskar, Beena Hosdurg ; Mulki, Shalini Shenoy ; Joshi, Sangeeta ; Adhikari, Ranjeeta ; Venkatesh, Bhavana Malavalli. / Colistin resistance in carbapenem-resistant Klebsiella pneumoniae strains. In: Asian Journal of Pharmaceutical and Clinical Research. 2017 ; Vol. 10, No. 9. pp. 70-73.
@article{6d34315daad649aeb956f3b4c859e5bd,
title = "Colistin resistance in carbapenem-resistant Klebsiella pneumoniae strains",
abstract = "Objective: There is an increasing use of colistin consequent to increase in the infections caused by carbapenem-resistant Klebsiella pneumoniae. The present study was conducted to determine the minimum inhibitory concentration (MIC) of colistin and the resistance pattern of colistin in carbapenem-resistant K. pneumoniae (CRKP) strains in our intensive care unit (ICU). Methods: Antibiotic susceptibility testing for other antimicrobial agents was done by Kirby-Bauer disk diffusion method. MIC of colistin was determined by agar dilution method. The results of antibiotic susceptibility testing were interpreted as per Clinical Laboratory Standard Institute guidelines 2016 and MIC of colistin were interpreted as per European Committee on Antimicrobial susceptibility testing. The carbapenem resistance was phenotypically detected by modified hodge test and imipenem/imipenem ethylenediaminetetraacetic acid disk method. Results: Out of 518 K. pneumoniae, 329 were resistant to carbapenems, and 91 isolates showed resistance to colistin. The MIC of colistin ranged between 4 and >512 ug/ml and MIC90 was 16 ug/L and MIC50 was 4 ug/ml. A majority of the colistin-resistant isolates were found in multidisciplinary ICU (85/91). Conclusion: The emergence of colistin-resistant strains is a major problem due to limited treatment options for infections caused by CRKP carbapenemase producing K. pneumoniae. Colistin should not be used alone, combination therapy should be preferred.",
author = "Bhaskar, {Beena Hosdurg} and Mulki, {Shalini Shenoy} and Sangeeta Joshi and Ranjeeta Adhikari and Venkatesh, {Bhavana Malavalli}",
year = "2017",
month = "1",
day = "1",
doi = "10.22159/ajpcr.2017.v10i9.18369",
language = "English",
volume = "10",
pages = "70--73",
journal = "Asian Journal of Pharmaceutical and Clinical Research",
issn = "0974-2441",
publisher = "Innovare Academics Sciences Pvt. Ltd",
number = "9",

}

Colistin resistance in carbapenem-resistant Klebsiella pneumoniae strains. / Bhaskar, Beena Hosdurg; Mulki, Shalini Shenoy; Joshi, Sangeeta; Adhikari, Ranjeeta; Venkatesh, Bhavana Malavalli.

In: Asian Journal of Pharmaceutical and Clinical Research, Vol. 10, No. 9, 01.01.2017, p. 70-73.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Colistin resistance in carbapenem-resistant Klebsiella pneumoniae strains

AU - Bhaskar, Beena Hosdurg

AU - Mulki, Shalini Shenoy

AU - Joshi, Sangeeta

AU - Adhikari, Ranjeeta

AU - Venkatesh, Bhavana Malavalli

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Objective: There is an increasing use of colistin consequent to increase in the infections caused by carbapenem-resistant Klebsiella pneumoniae. The present study was conducted to determine the minimum inhibitory concentration (MIC) of colistin and the resistance pattern of colistin in carbapenem-resistant K. pneumoniae (CRKP) strains in our intensive care unit (ICU). Methods: Antibiotic susceptibility testing for other antimicrobial agents was done by Kirby-Bauer disk diffusion method. MIC of colistin was determined by agar dilution method. The results of antibiotic susceptibility testing were interpreted as per Clinical Laboratory Standard Institute guidelines 2016 and MIC of colistin were interpreted as per European Committee on Antimicrobial susceptibility testing. The carbapenem resistance was phenotypically detected by modified hodge test and imipenem/imipenem ethylenediaminetetraacetic acid disk method. Results: Out of 518 K. pneumoniae, 329 were resistant to carbapenems, and 91 isolates showed resistance to colistin. The MIC of colistin ranged between 4 and >512 ug/ml and MIC90 was 16 ug/L and MIC50 was 4 ug/ml. A majority of the colistin-resistant isolates were found in multidisciplinary ICU (85/91). Conclusion: The emergence of colistin-resistant strains is a major problem due to limited treatment options for infections caused by CRKP carbapenemase producing K. pneumoniae. Colistin should not be used alone, combination therapy should be preferred.

AB - Objective: There is an increasing use of colistin consequent to increase in the infections caused by carbapenem-resistant Klebsiella pneumoniae. The present study was conducted to determine the minimum inhibitory concentration (MIC) of colistin and the resistance pattern of colistin in carbapenem-resistant K. pneumoniae (CRKP) strains in our intensive care unit (ICU). Methods: Antibiotic susceptibility testing for other antimicrobial agents was done by Kirby-Bauer disk diffusion method. MIC of colistin was determined by agar dilution method. The results of antibiotic susceptibility testing were interpreted as per Clinical Laboratory Standard Institute guidelines 2016 and MIC of colistin were interpreted as per European Committee on Antimicrobial susceptibility testing. The carbapenem resistance was phenotypically detected by modified hodge test and imipenem/imipenem ethylenediaminetetraacetic acid disk method. Results: Out of 518 K. pneumoniae, 329 were resistant to carbapenems, and 91 isolates showed resistance to colistin. The MIC of colistin ranged between 4 and >512 ug/ml and MIC90 was 16 ug/L and MIC50 was 4 ug/ml. A majority of the colistin-resistant isolates were found in multidisciplinary ICU (85/91). Conclusion: The emergence of colistin-resistant strains is a major problem due to limited treatment options for infections caused by CRKP carbapenemase producing K. pneumoniae. Colistin should not be used alone, combination therapy should be preferred.

UR - http://www.scopus.com/inward/record.url?scp=85029580409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029580409&partnerID=8YFLogxK

U2 - 10.22159/ajpcr.2017.v10i9.18369

DO - 10.22159/ajpcr.2017.v10i9.18369

M3 - Article

VL - 10

SP - 70

EP - 73

JO - Asian Journal of Pharmaceutical and Clinical Research

JF - Asian Journal of Pharmaceutical and Clinical Research

SN - 0974-2441

IS - 9

ER -